US 11110067
Inhibition of mammalian target of rapamycin
granted A61KA61K31/00A61K31/436
Quick answer
US patent 11110067 (Inhibition of mammalian target of rapamycin) held by The Board of Regents of the University of Texas System expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/00, A61K31/436, A61K45/06, A61K9/1635